GLP-1R agonists—the new weapon against obesity?

被引：0
|
作者：
Linda Koch
机构：
来源：
Nature Reviews Endocrinology | 2012年 / 8卷 / 4期
关键词：
D O I：
10.1038/nrendo.2012.13
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：196 / 196
相关论文
共 50 条
  • [1] GLP-1R AGONISTS AND WEIGHT LOSS GLP-1R agonists are not a quick fix for weight loss
    Iverson, Kristen A.
    BMJ-BRITISH MEDICAL JOURNAL, 2012, 344
  • [2] The effect of GLP-1R agonists on the medical triad of obesity, diabetes, and cancer
    Ibrahim, Shahad Sabaawi
    Ibrahim, Raghad Sabaawi
    Arabi, Batoul
    Brockmueller, Aranka
    Shakibaei, Mehdi
    Busselberg, Dietrich
    CANCER AND METASTASIS REVIEWS, 2024, 43 (04) : 1297 - 1314
  • [3] GLP-1R Agonists in Psoriasis Patients
    Mcadam, Rochelle F.
    Vender, Ronald
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2024, 28 (01) : 91 - 92
  • [4] Are GLP-1R agonists the long-sought-after panacea for obesity?
    Dowsett, Georgina K. C.
    Yeo, Giles S. H.
    TRENDS IN MOLECULAR MEDICINE, 2023, 29 (10) : 777 - 779
  • [5] GLP-1R AGONISTS AND WEIGHT LOSS Utility of GLP-1R agonists in diabetes requires long term study
    Franco de Oliveira, Jose Mario
    BMJ-BRITISH MEDICAL JOURNAL, 2012, 344
  • [6] GLP-1R agonists for the treatment of obesity: a patent review (2015-present)
    Liu, Chunxia
    Zou, Yuxing
    Qian, Hai
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2020, 30 (10) : 781 - 794
  • [7] GLP-1R Agonists Modulate Enteric Immune Responses Through the Intestinal Intraepithelial Lymphocyte GLP-1R
    Yusta, Bernardo
    Baggio, Laurie L.
    Koehler, Jacqueline
    Holland, Dianne
    Cao, Xiemin
    Pinnell, Lee J.
    Johnson-Henry, Kathene C.
    Yeung, William
    Surette, Michael G.
    Bang, K. W. Annie
    Sherman, Philip M.
    Drucker, Daniel J.
    DIABETES, 2015, 64 (07) : 2537 - 2549
  • [8] Rational Design of Small Molecular GLP-1R Agonists
    Yang, Zixin
    Kuang, Zhengkun
    Wang, Rui
    Pi, Ni
    Cheng, Xiyao
    Huang, Yongqi
    Su, Zhengding
    BIOPHYSICAL JOURNAL, 2021, 120 (03) : 27A - 27A
  • [9] GLP-1R Agonists Therapy for Type 2 Diabetes
    ZHOU Bilan
    PENG Anlin
    GONG Hao
    HUANG Kun
    WuhanUniversityJournalofNaturalSciences, 2014, 19 (01) : 27 - 33
  • [10] Prolonged exposure to long-acting GLP-1R agonists selectively desensitizes the β cell response to GLP-1R activation
    Kim, J
    Baggio, L
    Estall, J
    Drucker, D
    DIABETES, 2003, 52 : A323 - A324
12345